JUNCTURE WEALTH STRATEGIES, LLC

Position in CPRX — Catalyst Pharmaceuticals, Inc.

CIK 1632866 SCOTTSDALE, AZ

Position in CPRX

as of Jun 30, 2026 · filed Jul 9, 2026 Compact

Position Value

$578,563

+$578,563 QoQ

Shares Held

18,408

-74.4% QoQ

Ownership

0.015%

of shares outstanding

% of Portfolio

0.83%

of 13F equity value

Holder Rank

#47

of 119 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

JUNCTURE WEALTH STRATEGIES, LLC holds $4,939,567 across 9 Biotechnology names. CPRX ranks #4 (11.7% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	HALO	Halozyme Therapeutics, Inc.	11,865	$928,673
2	PTCT	Ptc Therapeutics, Inc.	10,577	$862,765
3	AUPH	Aurinia Pharmaceuticals Inc.	34,232	$580,917
4	CPRX	Catalyst Pharmaceuticals, Inc. This page	18,408	$578,563
5	MIRM	Mirum Pharmaceuticals, Inc.	4,815	$563,692
6	INCY	Incyte Corp	4,956	$561,812
7	VCEL	Vericel Corp	8,283	$368,510
8	TBPH	Theravance Biopharma, Inc.	17,234	$292,978

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$578,563	18,408	-74.4%	Shares	Sole	2026-07-09
2026-03-31	—	71,809	-14.9%	Shares	Sole	2026-04-15
2025-12-31	—	84,342	+1.1%	Shares	Sole	2026-01-27
2025-09-30	—	83,402	-8.6%	Shares	Sole	2025-10-14
2025-06-30	—	91,299	-5.0%	Shares	Sole	2025-07-08
2025-03-31	—	96,124	-1.3%	Shares	Sole	2025-04-10
2024-12-31	—	97,397	+0.2%	Shares	Sole	2025-01-21
2024-09-30	—	97,237	+0.5%	Shares	Sole	2024-10-09
2024-06-30	—	96,801	+2.3%	Shares	Sole	2024-07-11
2024-03-31	—	94,583	+764.0%	Shares	Sole	2024-04-05
2023-12-31	—	10,947	-1.3%	Shares	Sole	2024-01-08
2023-09-30	—	11,087	-71.9%	Shares	Sole	2023-10-10
2023-06-30	—	39,474	-2.2%	Shares	Sole	2023-07-12
2023-03-31	—	40,382	—	Shares	Sole	2023-05-05
No filing history on record for this holder in this stock.